Working together to
promote the advance
of all aspects of
cancer research.

Scientific Officer 2: Development of Novel Biomarker Assays Clinical and Experimental Pharmacology Group

  • ·  Starting Salary: from £19,600 - £22,700 per annum (dependent upon experience)
  • ·  Job Ref: MI/17/50
  • ·  Duration of post: Fixed term until 31 March 2022

The Clinical and Experimental Pharmacology Group (CEP) aim to enhance clinical trials of new anticancer therapies through biomarker research. Two positions funded by the NIHR Manchester Biomedical Research Centre and the CRUK Manchester Experimental Cancer Medicine Centre are available for experienced Scientific Officers to join our newly established Tumour Immunology and Inflammation Monitoring Laboratory within the Manchester Centre for Cancer Biomarker Sciences.  The successful candidates will drive forward the development of novel biomarker assays to monitor immune status and therapy responses, for example via inflammatory markers, cytokine levels and immune cell subpopulations, with a view to deploying the assays on samples from immunotherapy clinical trials.  All the required training and supervision will be provided.

The successful candidate will possess a bachelor’s degree in an appropriate scientific discipline (or equivalent relevant experience) e.g. immunology, biology, biochemistry, or medical sciences. Also required is first-hand experience of a range of  assay techniques used in the laboratory to assess immunological endpoints, e.g. immunocytochemistry, immunofluorescence and multiparameter flow cytometry, along with a track record of success in the implementation and utilisation of such assays, e.g. in a clinical setting or for research publications. Highly desirable is previous experience of working in a cancer research setting, ideally to Good Clinical Practice (GCP) standards. Also desirable is familiarity with computer databases in a laboratory setting, e.g. Laboratory Information Management Systems (LIMS).

These posts are funded from 1st April 2017. Informal enquiries should be directed to Dr Elaine Kilgour, e-mail:, please copy Ekram Aidaros (

The Cancer Research UK Manchester Institute (, an Institute of The University of Manchester (, is a world-leading centre for excellence in cancer research.  The Institute is core funded by Cancer Research UK (, the largest independent cancer research organisation in the world.  They are adjacent to The Christie NHS Foundation Trust (, one of the largest cancer treatment centres in Europe.  These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry. 

To apply for this position please visit their website:

For applicants who are unable to download this information from their website, please contact HR department on 0161 446 3231 or, email: to have this information sent by post.

The deadline for receipt of applications is: 22nd March 2017


Interviews to be held on 3rd April 2017.


Start Date

17th February 2017

Closing Date

22nd March 2017